I don't know when this is going to be ready to be moved to clinical trial, but they're going step by step, because the problem is that you worry about creating an anti-immune reaction against something that you start with to be helpful. What they're worried about is curing one thing and causing a secondary phenomenon that can be really deleterious to the nervous system.
Progress is good.